Geode Capital Management, LLC Forte Biosciences, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

Shares

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 09, 2024	BUY	$0.46 - $0.78 $1,315 - $2,230	2,860 Added 0.83%	346,292 $186,000
Q1 2024 May 13, 2024	BUY	$0.48 - $0.85 $3,276 - $5,802	6,827 Added 2.03%	343,432 $240,000
Q4 2023 Feb 13, 2024	BUY	$0.38 - $0.82 $48,724 - $105,142	128,222 Added 61.53%	336,605 $276,000
Q3 2023 Nov 13, 2023	BUY	$0.65 - $1.04 $9,782 - $15,652	15,050 Added 7.78%	208,383 $137,000
Q2 2023 Aug 11, 2023	BUY	$0.98 - $1.11 $140 - $158	143 Added 0.07%	193,333 $201,000
Q1 2023 May 15, 2023	BUY	$0.98 - $1.06 $727 - $786	742 Added 0.39%	193,190 $195,000
Q4 2022 Feb 13, 2023	BUY	$0.96 - $28.0 $1,339 - $39,060	1,395 Added 0.73%	192,448 $192,000
Q3 2022 Nov 14, 2022	BUY	$1.06 - $27.75 $4,722 - $123,626	4,455 Added 2.39%	191,053 $204,000
Q2 2022 Aug 12, 2022	SELL	$1.07 - $1.55 $75,208 - $108,946	-70,288 Reduced 27.36%	186,598 $242,000
Q1 2022 May 13, 2022	BUY	$1.21 - $2.24 $1,712 - $3,169	1,415 Added 0.55%	256,886 $375,000
Q4 2021 Feb 11, 2022	BUY	$2.02 - $3.36 $311,253 - $517,728	154,086 Added 151.98%	255,471 $546,000
Q3 2021 Nov 12, 2021	SELL	$2.96 - $36.67 $228,076 - $2.83 Million	-77,053 Reduced 43.18%	101,385 $300,000
Q2 2021 Aug 13, 2021	BUY	$31.5 - $42.5 $2.86 Million - $3.86 Million	90,880 Added 103.79%	178,438 $6 Million
Q1 2021 May 12, 2021	BUY	$25.01 - $40.24 $239,345 - $385,096	9,570 Added 12.27%	87,558 $3 Million
Q4 2020 Feb 12, 2021	BUY	$28.66 - $46.79 $43,419 - $70,886	1,515 Added 1.98%	77,988 $2.84 Million
Q3 2020 Nov 13, 2020	BUY	$14.71 - $50.69 $838,808 - $2.89 Million	57,023 Added 293.18%	76,473 $3.71 Million
Q2 2020 Aug 13, 2020	BUY	$13.9 - $24.6 $270,355 - $478,470	19,450 New	19,450 $283,000

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$3.19 Million
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $371M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.